Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Screening for Hodgkin Lymphoma Survivors: a Feasibility Study

NCT04986189 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT04986189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04986189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Screening for Hodgkin Lymphoma Survivors: a Feasibility Study
Lead sponsor
The Christie NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2021
Completion date
August 31, 2024
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, lung cancer